Douglas Loe
Stock Analyst at Leede Financial
(4.63)
# 837
Out of 4,349 analysts
152
Total ratings
47%
Success rate
22.1%
Average return
Main Sectors:
Stocks Rated by Douglas Loe
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| TSX: MSCL Satellos Bioscience Inc. | Maintained: Buy | $22.17 | $9.64 | +129.95% | 3 | Mar 11, 2026 | |
| TSXV: PINK Perimeter Medical Imaging AI, Inc. | Reiterated: Buy | $3.00 | $0.33 | +809.09% | 3 | Mar 8, 2026 | |
| TSXV: NSCI Nanalysis Scientific Corp. | Maintained: Buy | $0.50 | $0.14 | +257.14% | 1 | Nov 27, 2025 | |
| ONCY Oncolytics Biotech | Maintained: Buy | $8.5 → $4 | $0.935 | +327.81% | 18 | Nov 25, 2025 | |
| TSX: CRDL Cardiol Therapeutics Inc. | Maintained: Buy | $6.23 → $15.24 | $1.79 | +751.41% | 5 | Aug 8, 2025 | |
| PMN ProMIS Neurosciences | Maintained: Buy | n/a | $10.50 | - | 2 | Jul 22, 2025 | |
| TSX: DR Medical Facilities Corporation | Maintained: Buy | $4.50 → $15.50 | $17.23 | n/a | 7 | Aug 7, 2024 | |
| TSX: SVA Sernova Biotherapeutics Inc | Maintained: Buy | $3.30 → $4.57 | $0.14 | n/a | 9 | Jun 30, 2023 | |
| TSX: EXE Extendicare Inc. | Maintained: Hold | $8.25 → $7.00 | $32.32 | n/a | 13 | May 8, 2023 | |
| IMVIF IMV Inc. | Reiterated: Buy | $7.58 → $43 | $0.000001 | n/a | 18 | Apr 12, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $2.75 → $0.25 | $0.015 | n/a | 3 | Feb 28, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Sell | $1.01 → $0.11 | $2.43 | n/a | 12 | Aug 31, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $3.61 | $0.000001 | n/a | 13 | Aug 27, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $7.00 | $3.43 | n/a | 12 | Aug 14, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $27.00 → $29.00 | $41.31 | n/a | 4 | Aug 14, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $3.00 | $16.51 | n/a | 17 | Aug 13, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $37.50 | $9.57 | n/a | 6 | Aug 7, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | n/a | $0.000001 | n/a | 2 | Jun 16, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $34 → $1 | $4.60 | n/a | 4 | Oct 7, 2019 |
Satellos Bioscience Inc.
Mar 11, 2026
Maintained: Buy
Price Target: $22.17
Current: $9.64
Upside: +129.95%
Perimeter Medical Imaging AI, Inc.
Mar 8, 2026
Reiterated: Buy
Price Target: $3.00
Current: $0.33
Upside: +809.09%
Nanalysis Scientific Corp.
Nov 27, 2025
Maintained: Buy
Price Target: $0.50
Current: $0.14
Upside: +257.14%
Oncolytics Biotech
Nov 25, 2025
Maintained: Buy
Price Target: $8.5 → $4
Current: $0.935
Upside: +327.81%
Cardiol Therapeutics Inc.
Aug 8, 2025
Maintained: Buy
Price Target: $6.23 → $15.24
Current: $1.79
Upside: +751.41%
ProMIS Neurosciences
Jul 22, 2025
Maintained: Buy
Price Target: n/a
Current: $10.50
Upside: -
Medical Facilities Corporation
Aug 7, 2024
Maintained: Buy
Price Target: $4.50 → $15.50
Current: $17.23
Upside: n/a
Sernova Biotherapeutics Inc
Jun 30, 2023
Maintained: Buy
Price Target: $3.30 → $4.57
Current: $0.14
Upside: n/a
Extendicare Inc.
May 8, 2023
Maintained: Hold
Price Target: $8.25 → $7.00
Current: $32.32
Upside: n/a
IMV Inc.
Apr 12, 2022
Reiterated: Buy
Price Target: $7.58 → $43
Current: $0.000001
Upside: n/a
Feb 28, 2022
Maintained: Hold
Price Target: $2.75 → $0.25
Current: $0.015
Upside: n/a
Aug 31, 2020
Downgraded: Sell
Price Target: $1.01 → $0.11
Current: $2.43
Upside: n/a
Aug 27, 2020
Maintained: Buy
Price Target: $3.61
Current: $0.000001
Upside: n/a
Aug 14, 2020
Maintained: Buy
Price Target: $7.00
Current: $3.43
Upside: n/a
Aug 14, 2020
Maintained: Hold
Price Target: $27.00 → $29.00
Current: $41.31
Upside: n/a
Aug 13, 2020
Maintained: Buy
Price Target: $3.00
Current: $16.51
Upside: n/a
Aug 7, 2020
Maintained: Buy
Price Target: $37.50
Current: $9.57
Upside: n/a
Jun 16, 2020
Maintained: Buy
Price Target: n/a
Current: $0.000001
Upside: n/a
Oct 7, 2019
Downgraded: Hold
Price Target: $34 → $1
Current: $4.60
Upside: n/a